There is arguments at Novartis, the boss CEO has been criticised by investors and board for not investing enough for the future. Could be the reason why they didn’t invest in MSB. That’s they link from the Swiss paper Blick. Sorry my English is not the best.
https://www.blick.ch/wirtschaft/muss-vas-narasimhanhttps://www.blick.ch/wirtschaft/muss-vas-narasimhan-bald-gehen-insider-beklagen-personenkult-beim-novartis-chef-id17098925.html?utm_medium=social&utm_campaign=share-button&utm_source=copy-to-clipboard-bald-gehen-insider-beklagen-personenkult-beim-novartis-chef-id17098925.html?utm_medium=social&utm_campaign=share-button&utm_source=copy-to-clipboardhttps://www.blick.ch/wirtschaft/muss-vas-narasimhan-bald-gehen-insider-beklagen-personenkult-beim-novartis-chef-id17098925.html?utm_medium=social&utm_campaign=share-button&utm_source=copy-to-clipboard
- Forums
- ASX - By Stock
- Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
There is arguments at Novartis, the boss CEO has been criticised...
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.07 |
Change
-0.030(2.73%) |
Mkt cap ! $1.221B |
Open | High | Low | Value | Volume |
$1.11 | $1.21 | $1.05 | $28.73M | 25.63M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 14264 | $1.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 24626 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 14264 | 1.070 |
5 | 119100 | 1.065 |
2 | 50550 | 1.060 |
4 | 222779 | 1.055 |
15 | 223822 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.075 | 20000 | 2 |
1.080 | 19287 | 3 |
1.085 | 44092 | 3 |
1.090 | 5912 | 1 |
1.095 | 100000 | 1 |
Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.08 |
  |
Change
-0.030 ( 2.52 %) |
|||
Open | High | Low | Volume | ||
$1.10 | $1.21 | $1.05 | 5190842 | ||
Last updated 15.59pm 02/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online